Palliative Oncology Symptoms Management Utilizing Beacon© Platform's Analysis of Aggregated Patient-Provided Data - Feasibility Prospective Study
Sponsor: Tzeela Cohen
Trial Details
| Condition | Cancer, Symptom, Quality of Life, AI (Artificial Intelligence) |
| Intervention | Advanced cancer patients' palliative symptoms management using Beacon analysis of patient-provided of objective and subjective data |
| Phase | NA |
| Status | Not_yet_recruiting |
| Participants | 40 |
| Est. Completion | 1 June 2027 |
| Last Updated | 9 Apr 2026 |
Primary Outcome
The number of physician's login into the Beacon platform, per patient, throughout the 12-week study period.; Percent of clinical palliative care encounters involving the use of the Beacon platform throughout the 12-week study.; The number of fields reviewed by the physician per login to the Beacon platform throughout the 12-week study period.; Beacon platform fields rating according to the physicians' reviewing frequency.; Physicians' rating of the Beacon-derived data contribution to clinical treatment decision-making/planning following each clinical encounter utilizing the Beacon platform.
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Outpatients treated and followed at the Davidoff Center * Stage III-IV cancer * Eastern Cooperative Oncology Group (ECOG) 0-3 * Age: 18 and older * Have not been engaged with the ambulatory palliative service over the last three months * Speaks and reads a language supported by the study protocol (e.g., Hebrew, Arabic, English) * Able to wear a smartwatch/sensor for prolonged periods and independently operate the app * Actively symptomatic patients requiring palliative care (not long-term stable survivors) * Enrolled in another clinical study if the existing study allows Exclusion Criteria: * Patient without active disease * Patients are actively engaged with the ambulatory palliative service in the - Davidoff Center or elsewhere * Patient with chronic stable symptoms (\>6 months) related to their cancer or treatment * ECOG \> 3 * Does not speak and read languages supported by the study protocol (e.g., Hebrew, Arabic, English) * Legal incompetence * Does not or cannot use a smartphone, or is unable to fill out questionnaires/record messages, or is unable to wear a smartwatch/sensor, or operate the app independently
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service